MARKET

DXCM

DXCM

Dexcom Inc
NASDAQ
61.63
+3.81
+6.59%
After Hours: 61.50 -0.13 -0.21% 19:39 05/15 EDT
OPEN
59.91
PREV CLOSE
57.82
HIGH
63.19
LOW
59.46
VOLUME
11.13M
TURNOVER
--
52 WEEK HIGH
89.98
52 WEEK LOW
54.11
MARKET CAP
23.78B
P/E (TTM)
26.59
1D
5D
1M
3M
1Y
5Y
1D
Is It Time To Revisit DexCom (DXCM) After Share Price Weakness And DCF Upside?
Simply Wall St · 6h ago
DexCom Inc. Stock Advances 6.6%, Outperforms Peers
Dow Jones · 18h ago
DexCom Inc. stock outperforms competitors on strong trading day
MarketWatch · 18h ago
BUZZ-U.S. STOCKS ON THE MOVE-Intel, Nvidia, Aardvark
Reuters · 21h ago
Diabetes Tech Player DexCom Lays Out 2030 Growth Vision
Benzinga · 21h ago
Morning News Wrap-Up, 5/15/26: Today’s Biggest Stock Market Stories!
TipRanks · 21h ago
Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Galectin Therapeutics (GALT)
TipRanks · 21h ago
BUZZ-U.S. STOCKS ON THE MOVE-Exxon Mobil, Intel, Nvidia
Reuters · 22h ago
More
About DXCM
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. It enables people to take control of health through innovative biosensing technology. The G7 is an integrated continuous glucose monitoring system. Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes. The G7 and G7 15 Day includes finger stick elimination, continuous glucose readings and others.

Webull offers DexCom Inc stock information, including NASDAQ: DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.